BLUE STREAK, L.L.C. – Trademark Portfolio

Entity Type: 16

BLUE STREAK, L.L.C. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 11 (Environmental Control) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BLUE STREAK and BLUE STREAK CHEMICAL. The owner is based in MASON, MI.

904 NORTH COLLEGE ROAD

MASON, MI 48854

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BLUE STREAK, L.L.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

Frequently Asked Questions

How many trademarks does BLUE STREAK, L.L.C. have?

BLUE STREAK, L.L.C. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does BLUE STREAK, L.L.C. file in?

BLUE STREAK, L.L.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 11 (Environmental Control). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BLUE STREAK, L.L.C.'s most well-known trademarks?

BLUE STREAK, L.L.C.'s registered trademark portfolio includes well-known marks such as BLUE STREAK and BLUE STREAK CHEMICAL. These are among 3 currently registered trademarks in the portfolio.

What is BLUE STREAK, L.L.C.'s trademark registration success rate?

BLUE STREAK, L.L.C. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.